| Not Yet Recruiting | the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles, Rubella | — | 2026-01-30 |
| Recruiting | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. Smallpox, Cowpox, Monkeypox | Phase 1 | 2025-08-28 |
| Unknown | A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Yea Varicella | Phase 3 | 2023-04-27 |
| Active Not Recruiting | A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine Varicella | Phase 3 | 2022-12-26 |
| Unknown | Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population Hemolysis, COVID-19 | Phase 4 | 2022-08-05 |
| Unknown | Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabi COVID-19, Rabies | Phase 4 | 2022-07-21 |
| Unknown | Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 1 COVID-19 | Phase 3 | 2022-05-27 |
| Unknown | Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Va COVID-19 | Phase 3 | 2022-05-10 |
| Unknown | A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Popu COVID-19 | Phase 1 / Phase 2 | 2022-05-01 |
| Unknown | Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infe COVID-19, HIV Infections | Phase 4 | 2021-12-01 |
| Unknown | Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With COVID-19, Chronic Bronchitis, COPD | Phase 4 | 2021-12-01 |
| Unknown | Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) COVID-19 Pneumonia | Phase 4 | 2021-11-01 |
| Unknown | Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing COVID-19 Pneumonia | Phase 4 | 2021-11-01 |
| Active Not Recruiting | A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsor Whooping Cough, Diphtheria, Tetanus | Phase 3 | 2021-10-22 |
| Unknown | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchiti COVID-19, Chronic Bronchitis, Copd | Phase 4 | 2021-10-08 |
| Unknown | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected HIV Infections, COVID-19 | Phase 4 | 2021-10-08 |
| Unknown | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COP COVID-19, Chronic Bronchitis, COPD | Phase 4 | 2021-10-08 |
| Unknown | Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected COVID-19, HIV Infections | Phase 4 | 2021-10-08 |
| Completed | Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertensio COVID-19 Pneumonia | Phase 4 | 2021-10-05 |
| Unknown | Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension COVID-19 Pneumonia | Phase 4 | 2021-10-01 |
| Completed | Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old a COVID-19 Pneumonia, COVID-19 | Phase 3 | 2021-07-02 |
| Unknown | Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 Influenza, Human, Pneumonia, Pneumococcal, COVID-19 Pneumonia | Phase 4 | 2021-05-06 |
| Unknown | A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated Covid19 | Phase 4 | 2021-04-29 |
| Completed | A Clinical Trial to Evaluate the Immunogenicity and Safety of PPV23 Vaccine Revaccinations in the Elderly Vaccination | Phase 4 | 2021-03-30 |
| Completed | A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old Vaccination | Phase 4 | 2021-03-21 |
| Completed | Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and Influenza, Human, Pneumonia, Pneumococcal, Covid19 | Phase 4 | 2021-03-10 |
| Unknown | Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR Vaccine | Phase 4 | 2020-11-13 |
| Unknown | Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine Vaccination | Phase 4 | 2020-11-12 |
| Unknown | Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA Vaccination | Phase 4 | 2020-11-11 |
| Completed | Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4 Influenza, Human, Pneumonia, Pneumococcal | Phase 4 | 2020-09-11 |
| Completed | A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in COVID-19 | Phase 3 | 2020-07-16 |
| Completed | Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vac Enterovirus Infections, Influenza | Phase 4 | 2019-09-26 |
| Completed | Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP Vaccination | Phase 4 | 2019-08-16 |
| Unknown | Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP Vaccination | Phase 4 | 2019-08-10 |
| Completed | To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV Vaccination, Reaction - Vaccine | Phase 4 | 2018-03-01 |
| Completed | Immunogenicity and Safety of Sabin-IPV Replacement Vaccination Vaccination | Phase 4 | 2018-03-01 |
| Unknown | Comparative Immunogenicity Study of Two Hepatitis A Vaccines Hepatitis A | Phase 4 | 2017-07-26 |